Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02960295 · ClinicalTrials.gov registry record · NA
The Virtual Visit for Women With Gestational Diabetes
A NA study, sponsored by Kaiser Permanente.
- Completed
- Registry status
- NA
- Development phase
- 10
- Enrollment target
NCT02960295 is a NA study that has completed, run by Kaiser Permanente. The registered enrollment target is 10 participants.
The verdict
NCT02960295, a NA study, has completed, sponsored by Kaiser Permanente.
- COMPLETED
- Registry status
- NA
- Development phase
- 10 participants
- Enrollment target
Study Summary
This is a feasibility study of care for women with gestational diabetes (GDM) using electronic equipment to participate in virtual office visits. Participants will be trained in the use of glucose meters, scales, and sphygmomanometers which are Bluetooth connected to an app on their cellphones. Fetal well-being will be assessed with Dopplers and kick counts. Care will be delivered by alternate in-office and telephone visits.
Interventions
- DEVICE 1-Self-monitoring of blood glucose
- DEVICE 2-Self-weighing
- DEVICE 3-Self-checking of blood pressure
- DEVICE 4-Checking fetal heart rate
- PROCEDURE 5-Visits with caregivers
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 10 participants |
| Start Date | 2014-09 |
| Est. Completion | 2016-09 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02960295
The ClinicalTrials.gov registry entry for NCT02960295 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 10 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Kaiser Permanente, which has 294 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 5 interventions - of which 1-Self-monitoring of blood glucose is the first listed.
NCT02960295 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02960295 about?
NCT02960295 is a clinical study titled "The Virtual Visit for Women With Gestational Diabetes". This is a feasibility study of care for women with gestational diabetes (GDM) using electronic equipment to participate in virtual office visits. Participants will be trained in the use of glucose meters, scales, and sphygmomanometers which are Bluetooth connected to an app on their cellphones. Fet...
What is the current status of trial NCT02960295?
This trial is currently completed. It is a NA study. The enrollment target is 10 participants. The study started on 2014-09. Estimated completion is 2016-09.
What interventions are being tested in trial NCT02960295?
The interventions under investigation include: 1-Self-monitoring of blood glucose (DEVICE), 2-Self-weighing (DEVICE), 3-Self-checking of blood pressure (DEVICE), 4-Checking fetal heart rate (DEVICE), 5-Visits with caregivers (PROCEDURE).
Who is sponsoring clinical trial NCT02960295?
This trial is sponsored by Kaiser Permanente, which has 294 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.